These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9666084)

  • 1. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain.
    Kokoshka JM; Metzger RR; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Brain Res; 1998 Jul; 799(1):78-83. PubMed ID: 9666084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and reversible effects of methamphetamine on dopamine transporters.
    Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
    J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and reversible change in dopamine transporters induced by methamphetamine.
    Fleckenstein AE; Metzger RR; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Apr; 323(2-3):R9-10. PubMed ID: 9128855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters.
    Haughey HM; Brown JM; Wilkins DG; Hanson GR; Fleckenstein AE
    Brain Res; 2000 Apr; 863(1-2):59-65. PubMed ID: 10773193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species.
    Berman SB; Hastings TG
    J Neurochem; 1997 Sep; 69(3):1185-95. PubMed ID: 9282942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen radicals diminish dopamine transporter function in rat striatum.
    Fleckenstein AE; Metzger RR; Beyeler ML; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Sep; 334(1):111-4. PubMed ID: 9346337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of volatile and intravenous anesthetics on the uptake of GABA, glutamate and dopamine by their transporters heterologously expressed in COS cells and in rat brain synaptosomes.
    Sugimura M; Kitayama S; Morita K; Irifune M; Takarada T; Kawahara M; Dohi T
    Toxicol Lett; 2001 Aug; 123(1):69-76. PubMed ID: 11514107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?
    Hanson GR; Gibb JW; Metzger RR; Kokoshka JM; Fleckenstein AE
    Ann N Y Acad Sci; 1998 May; 844():103-7. PubMed ID: 9668668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radical production induced by methamphetamine in rat striatal synaptosomes.
    Pubill D; Chipana C; Camins A; Pallàs M; Camarasa J; Escubedo E
    Toxicol Appl Pharmacol; 2005 Apr; 204(1):57-68. PubMed ID: 15781294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.
    Berman SB; Zigmond MJ; Hastings TG
    J Neurochem; 1996 Aug; 67(2):593-600. PubMed ID: 8764584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-induced alterations in dopamine transporter function.
    Bennett BA; Hollingsworth CK; Martin RS; Harp JJ
    Brain Res; 1998 Jan; 782(1-2):219-27. PubMed ID: 9519266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function.
    Metzger RR; Hanson GR; Gibb JW; Fleckenstein AE
    Eur J Pharmacol; 1998 May; 349(2-3):205-10. PubMed ID: 9671099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.
    Sandoval V; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2000 Dec; 409(3):265-71. PubMed ID: 11108820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function.
    Fleckenstein AE; Haughey HM; Metzger RR; Kokoshka JM; Riddle EL; Hanson JE; Gibb JW; Hanson GR
    Eur J Pharmacol; 1999 Oct; 382(1):45-9. PubMed ID: 10556503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.